The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis

World Journal of Surgical Oncology

Baoxue Yang⁴  Jie Zhang²  Wei Xu²  Ke Wang²  Lijing Zhao³  Chen Shao¹ 

[1] Department of Digestive Medicine, China–Japan Union Hospital of Jilin University, Changchun, Jilin, 130033, China;Department of Respiratory Medicine, the Second Affiliated Hospital of Jilin University, Changchun, Jilin, 130041, China;Department of Pathophysiology, Norman Bethune College of Medicine of Jilin University, Changchun, Jilin, 130021, China;Department of Pharmacology, School of Basic Medical Sciences of Peking University, Beijing, 100191, China

关键词: Xenograft mice model;    A549;    Apoptosis;    Lung adenocarcinoma;    RBM5;   

Others  :  827425
DOI  :  10.1186/1477-7819-10-160

 received in 2012-05-22, accepted in 2012-07-15,  发布年份 2012

【 摘 要 】

Background

The loss of tumor suppressor gene (TSG) function is a critical step in the pathogenesis of human lung cancer. RBM5 (RNA-binding motif protein 5, also named H37/LUCA-15) gene from chromosome 3p21.3 demonstrated tumor suppressor activity. However, the role of RBM5 played in the occurrence and development of lung cancer is still not well understood.

Method

Paired non-tumor and tumor tissues were obtained from 30 adenocarcinomas. The expression of RBM5 mRNA and protein was examined by RT-PCR and Western blot. A549 cell line was used to determine the apoptotic function of RBM5 in vitro. A549 cells were transiently transfected with pcDNA3.1-RBM5. AnnexinV analysis was performed by flow cytometry. Expression of Bcl-2, cleaved caspase-3, caspase-9 and PAPP proteins in A549 lung cancer cells and the A549 xenograft BALB/c nude mice model was determined by Western blot. Tumor suppressor activity of RBM5 was also examined in the A549 xenograft model treated with pcDNA3.1-RBM5 plasmid carried by attenuated Salmonella typhi Ty21a.

Result

The expression of RBM5 mRNA and protein was decreased significantly in adenocarcinoma tissues compared to that in the non-tumor tissues. In addition, as compared to the vector control, a significant growth inhibition of A549 lung cancer cells was observed when transfected with pcDNA3.1-RBM5 as determined by cell proliferation assay. We also found that overexpression of RBM5 induced both early and late apoptosis in A549 cells using AnnexinV/PI staining as determined by flow cytometry. Furthermore, the expression of Bcl-2 protein was decreased, whereas the expression of cleaved caspase-3, caspase-9 and PARP proteins was significantly increased in the RBM5 transfected cells; similarly, expression of decreased Bcl-2 and increased cleaved caspase-3 proteins was also examined in the A549 xenograft model. More importantly, we showed that accumulative and stable overexpression of RBM5 in the A549 xenograft BALB/c nude mice model significantly inhibited the tumor growth rate in vivo as compared to that in the control.

Conclusion

Our study demonstrates that RBM5 can inhibit the growth of lung cancer cells and induce apoptosis both in vitro and in vivo, which suggests that RBM5 might be used as a potential biomarker or target for lung cancer diagnosis and chemotherapy. Moreover, we propose a novel animal model set up in BALB/c nude mice treated with attenuated Salmonella as a vector carrying plasmids to determine RBM5 function in vivo.

【 授权许可】

   
2012 Shao et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
• [2]Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008, 83:584-594.
• [3]Wistuba II, Mao L, Gazdar AF: Smoking molecular damage in bronchial epithelium. Oncogene 2002, 21:7298-7306.
• [4]Razmkhah M, Doroudchi M, Ghayumi SMA, Erfani N, Ghaderi A: Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 2005, 49:311-315.
• [5]Alberg AJ, Ford JG, Samet JM: Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:29s-55s.
• [6]Angeloni D: Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct Genomic Proteomic 2007, 6:19-39.
• [7]Ying J, Poon FF, Yu J, Geng H, Wong AH, Qiu GH, Goh HK, Rha SY, Tian L, Chan AT, et al.: DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. Br J Cancer 2009, 100:663-669.
• [8]Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ: 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res 2006, 66:3419-3427.
• [9]Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ: RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. Lung Cancer 2010, 70:253-262.
• [10]Timmer T, Terpstra P, van den Berg A, Veldhuis PMJF, Ter Elst A, Voutsinas G, Hulsbeek MMF, Draaijers TG, Looman MWG, Kok K, et al.: A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3. Eur J Hum Genet 1999, 7:478-486.
• [11]Oh JJ, West AR, Fishbein MC, Slamon DJ: A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res 2002, 62:3207-3213.
• [12]Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, et al.: Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004, 23:5719-5728.
• [13]Sutherland LC, Edwards SE, Cable HC, Poirier GG, Miller BA, Cooper CS, Williams GT: LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 2000, 19:3774-3781.
• [14]ter Elst A, Hiemstra BE, van der Vlies P, Kamminga W, van der Veen AY, Davelaar I, Terpstra P, Meerman GJT, Gerbens F, Kok K, Buys CHCM: Functional analysis of lung tumor suppressor activity at 3p21.3. Genes Chromosomes Cancer 2006, 45:1077-1093.
• [15]Angeloni D, ter Elst A, Wei MH, van der Veen AY, Braga EA, Klimov EA, Timmer T, Korobeinikova L, Lerman MI, Buys CH: Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes. Genes Chromosomes Cancer 2006, 45:676-691.
• [16]Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54.
• [17]Rintala-Maki ND, Sutherland LC: LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis 2004, 9:475-484.
• [18]Sutherland LC, Lerman M, Williams GT, Miller BA: LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 2001, 20:2713-2719.
• [19]Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, et al.: p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. Int J Cancer 2011, 128:304-318.
• [20]Akhtar MJ, Ahamed M, Khan MA, Alrokayan SA, Ahmad I, Kumar S: Cytotoxicity and apoptosis induction by nanoscale talc particles from two different geographical regions in human lung epithelial cells. Environ Toxicol 2012.
• [21]Mu YM, Oba K, Yanase T, Ito T, Ashida K, Goto K, Morinaga H, Ikuyama S, Takayanagi R, Nawata H: Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21(WAF1)/CIP1. Endocr J 2003, 50:771-781.
• [22]Lin GM, Zhao LJ, Yin F, Lan RF, Li LB, Zhang XM, Zhang H, Yang BX: TCF3 inhibits F9 embryonal carcinoma growth by the down-regulation of Oct4. Oncol Rep 2011, 26:893-899.
• [23]Lerman MI, Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000, 60:6116-6133.
• [24]Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS: cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002, 23:736-748.
• [25]Edamatsu H, Kaziro Y, Itoh H: LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 2000, 5:849-858.
• [26]Kotlajich MV, Hertel KJ: Death by splicing: tumor suppressor RBM5 freezes splice-site pairing. Mol Cell 2008, 32:162-164.
• [27]Farina B, Fattorusso R, Pellecchia M: Targeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2-Type Zinc Finger of RBM5. ChemBioChem 2011, 12:2837-2845.
• [28]Maarabouni MM, Williams GT: The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update. ScientificWorldJournal 2006, 6:1705-1712.
• [29]Pawelek JM, Low KB, Bermudes D: Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997, 57:4537-4544.
• [30]Cryz SJ Jr, Vanprapar N, Thisyakorn U, Olanratmanee T, Losonsky G, Levine MM, Chearskul S: Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infect Immun 1993, 61:1149-1151.
• [31]Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM: Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 2010, 43:41-48.
• [32]Ji K, Wang B, Shao YT, Zhang L, Liu YN, Shao C, Li XJ, Li X, Hu JD, Zhao XJ, et al.: Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene In Vitro and In Vivo. J Pharmacol Exp Ther 2011, 338:173-183.
• [33]Shao Y, Liu Y, Shao C, Hu J, Li X, Li F, Zhang L, Zhao D, Sun L, Zhao X, et al.: Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein. Cancer Gene Ther 2010, 17:844-854.